CMA To Probe $295M Roche Diagnostics Deal
By Dawood Fakhir ( May 24, 2024, 5:41 PM BST) -- Britain's antitrust regulator said Friday that it has decided to launch a probe into Swiss drugmaker Roche's proposed $295 million purchase of parts of diagnostic company LumiraDx days after inviting public feedback to assess if the deal could harm competition....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.